Sago and Data Quality Co-op Announce Partnership to Advance Shared Data Quality Standards
Collaboration brings real-time quality indicators and the Data Trust Score™ into Sago’s research operations SALT LAKE CITY, Feb. 5, 2026 /PRNewswire/ — Sago,... Read more.
NITECORE Sets a New Standard for Ultralight Power: the New 143g, IPX7-Rated NB10000 Gen4
GUANGZHOU, China, Feb. 5, 2026 /PRNewswire/ — The NITECORE NB10000 Gen4 Ultra Lightweight Competition-Grade Power Bank, available since January 29, 2026, has... Read more.
MEDOME RELEASES SOLUTION TO END MISDIAGNOSIS IN PRIMARY CARE; WILL SAVE 100s OF THOUSANDS OF LIVES ANNUALLY
Medome is a first of its kind patented Advanced Health Intelligence ™ application for consumers based on its AI-First Primary Care model™ developed by physicians... Read more.
Gen Z’s Secret Love Lives Exposed: 1 in 3 Caught Texting During Sex (And 24 Texted Mom Back)
Anonymous Campus Apps Yik Yak and Sidechat Drop Valentine’s Day Bombshell Survey of 100,000 Students—Plus Launch Campus-Wide Cupid Algorithm NEW YORK, Feb.... Read more.
Wavelength Strategy Joins SKDK
Firms Combine Forces To Create Multi-Platform Advertising and Public Affairs Powerhouse WASHINGTON, Feb. 5, 2026 /PRNewswire/ — SKDK, one of the nation’s... Read more.
How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used... Read more.
Insightec Secures Health Canada Approval for Exablate® Prime System
New approval brings most advanced, efficient Exablate platform to Canada, expanding access to enhanced care for people living with essential tremor HAIFA, Israel... Read more.
DLG Launches LuxuryIQ MCP: The Luxury Industry’s First AI Data Integration Layer
GENEVA, Feb. 5, 2026 /PRNewswire/ — DLG (Digital Luxury Group) today announces LuxuryIQ MCP, the first Model Context Protocol integration designed specifically... Read more.
Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program
Atossa’s Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026... Read more.
Briya Appoints Brian Creighton to Accelerate Growth in AI-Driven Healthcare Data
NEW YORK, Feb. 5, 2026 /PRNewswire/ — Briya, the health AI technology company redefining healthcare research, today announced the appointment of Brian Creighton... Read more.